engpass.radarSwiss drug shortages
All G03GA02 shortages
Active substanceG03GA02

menotropinum

No active shortages currently reported for this substance.

11

Available

7

Off market

9

Resolved

Overview

menotropinum (ATC G03GA02) is an active substance in the ATC class G03GA. Switzerland has 18 medications approved with this active substance. No active supply shortages are currently reported for this active substance. Shortages of this active substance lasted on average 94 days in Switzerland (measured across 9 historical cases).

Possible alternatives from the same ATC class

Other active substances in the same ATC subgroup (G03GA). In case of shortage, a therapeutic alternative within the class may be possible — always coordinate substitution with a doctor or pharmacist:

0 products (filtered from 18)

Historical shortages

9 resolved entries archived for this substance.

Frequently asked questions

What is menotropinum?

This page shows the current supply situation for menotropinum in Switzerland: which products are available, which are in shortage, and what active-substance or class-level alternatives exist. For detailed pharmacological information, refer to the official prescribing information on swissmedicinfo.ch.

What is menotropinum used for?

The exact indications for menotropinum are documented in the prescribing information on swissmedicinfo.ch. This page focuses on supply status — in case of shortage, same-substance or same-class alternatives are listed above, but substitution should always be coordinated with a doctor or pharmacist.

What alternatives exist for menotropinum?

Same-substance alternatives (other brands, generics) are marked above with status "Available". Active-substance alternatives from the same ATC class can be found in the section "Possible alternatives from the same ATC class".

How frequent are shortages of menotropinum?

9 historical shortages are documented for this active substance in Switzerland. These lasted on average 94 days.

Set up shortage alert

Receive an email as soon as the situation for menotropinum changes.(3 free)

Unlimited alerts + API access: Engpassradar Pro from CHF 39/mo →

Shortage data: drugshortage.ch · Product catalogue: ODDB / Swissmedic · no warranty of completeness